The Financial Future of the Gene Therapy Market

Gene therapy has the potential to treat or even cure many chronic diseases, and as such, it has become an increasing area of focus for medical research. Researchers around the globe are investigating the application of gene therapy to HIV, diabetes, cancer, and many other serious conditions. A recent report by the market research firm RNCOS looked at the clinical applications of these treatments and how they could change the health care sector in the coming four years.

According to the report, titled “Global Gene Therapy Market Forecast to 2020,” the majority of research on gene therapy is done in the context of oncology, especially in relation to cancers that are traditionally resistant to treatment. However, the scope of gene therapy research is broad, encompassing developments in treating conditions from inherited blindness to cardiovascular disease.

So far, the vast majority of gene therapy products are still in the research and clinical development phase, with few therapies commercially available. The majority of financing in the field comes from funding, grants, and private investors. Promising clinical data, regulatory approvals, and commercial revenue are the key ingredients to fueling additional investment and excitement in the field.